Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

Reshaping Chromatin Architecture around DNA Breaks.

Caron P, Polo SE.

Trends Biochem Sci. 2019 Dec 24. pii: S0968-0004(19)30259-2. doi: 10.1016/j.tibs.2019.12.001. [Epub ahead of print]

PMID:
31882194
2.

Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study.

Petersenn S, Houchard A, Sert C, Caron PJ; PRIMARYS Study Group.

Pituitary. 2019 Dec 26. doi: 10.1007/s11102-019-01020-3. [Epub ahead of print]

PMID:
31879842
3.

Extragonadal Steroids Contribute Significantly to the Androgen Receptor Activity and Castration Resistance Development in Recurrent Prostate Cancers after Primary Therapy.

Pouliot F, Rouleau M, Neveu B, Toren P, Morin F, Vélot L, Ding K, Caron P, Lacombe L, Lévesque É, Klotz L, Guillemette C.

J Urol. 2019 Dec 17:101097JU0000000000000699. doi: 10.1097/JU.0000000000000699. [Epub ahead of print]

PMID:
31845837
4.

Associations between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Post-Menopausal Women.

Petrick JL, Florio AA, Zhang X, Zeleniuch-Jacquotte A, Wactawski-Wende J, Van Den Eeden SK, Stanczyk FZ, Simon TG, Sinha R, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Purdue MP, Palmer JR, Linet MS, Liao LM, Lee IM, Koshiol J, Kitahara CM, Kirsh VA, Hofmann JN, Guillemette C, Graubard BI, Giovannucci E, Gaziano JM, Gapster SM, Freedman ND, Engel LS, Chong DQ, Chen Y, Chan AT, Caron P, Buring JE, Bradwin G, Beane Freeman LE, Campbell PT, McGlynn KA.

Hepatology. 2019 Dec 5. doi: 10.1002/hep.31057. [Epub ahead of print]

PMID:
31808181
5.

Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.

Vaillancourt J, Turcotte V, Caron P, Villeneuve L, Lacombe L, Pouliot F, Lévesque É, Guillemette C.

Drug Metab Dispos. 2020 Feb;48(2):75-84. doi: 10.1124/dmd.119.088229. Epub 2019 Nov 14.

PMID:
31727674
6.

Is MRI follow-up relevant in patients with GH-secreting pituitary adenomas primarily treated and responsive to long-acting somatostatin analogues (SMSa)?

Grandgeorge N, Barchetti G, Grunenwald S, Bonneville F, Caron PJ.

Eur J Endocrinol. 2019 Nov 1. pii: EJE-19-0681.R1. doi: 10.1530/EJE-19-0681. [Epub ahead of print]

PMID:
31705796
7.

Self-Blame, Shame, Avoidance, and Suicidal Ideation in Sexually Abused Adolescent Girls: A Longitudinal Study.

Alix S, Cossette L, Cyr M, Frappier JY, Caron PO, Hébert M.

J Child Sex Abus. 2019 Nov 6:1-16. doi: 10.1080/10538712.2019.1678543. [Epub ahead of print]

PMID:
31692417
8.

[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update].

Comont T, Belliere J, Sibaud V, Alric L, Meyer N, Mazières J, Caron P, Acket B, Michot JM, Beyne-Rauzy O, Lambotte O.

Rev Med Interne. 2020 Jan;41(1):37-45. doi: 10.1016/j.revmed.2019.09.005. Epub 2019 Oct 24. French.

PMID:
31668882
9.

Letter to the editor « Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy ».

Chabre O, Young J, Caron P, Tabarin A.

J Clin Endocrinol Metab. 2019 Oct 28. pii: dgz105. doi: 10.1210/clinem/dgz105. [Epub ahead of print] No abstract available.

PMID:
31665316
10.

Effect of orbital radiotherapy on the outcome of surgical orbital decompression for thyroid-associated orbitopathy (TAO): a retrospective study in 136 patients.

Boulanouar L, Grunenwald S, Imbert P, Khalifa J, Dekeister C, Boutault F, Caron P.

Endocrine. 2019 Oct 23. doi: 10.1007/s12020-019-02113-6. [Epub ahead of print]

PMID:
31646433
11.

Weight-loss with activation of brown fat: Suspect pheochromocytoma.

Geslot A, Bennet A, Hitzel A, Thoulouzan M, Mouly C, Savagner F, Quintyn-Ranty ML, Caron P, Vezzosi D.

Ann Endocrinol (Paris). 2019 Nov;80(5-6):314-318. doi: 10.1016/j.ando.2019.06.004. Epub 2019 Jul 26.

PMID:
31606198
12.

La néoplasie endocrinienne multiple de type 1 : mise au point après le congrès de l’ENETS 2019: Multiple Endocrine Neoplasia Type 1: Development after the ENETS 2019 Congress.

Vialon M, Desailloud R, Caron P.

Ann Endocrinol (Paris). 2019 Sep;80 Suppl 1:S19-S28. doi: 10.1016/S0003-4266(19)30113-1. French.

PMID:
31606058
13.

Gestational diabetes and acromegaly: Single-centre experience of 14 pregnancies.

Vialon M, Grunenwald S, Mouly C, Vezzosi D, Bennet A, Gourdy P, Caron PJ.

Clin Endocrinol (Oxf). 2019 Dec;91(6):805-809. doi: 10.1111/cen.14097. Epub 2019 Oct 14.

PMID:
31520541
14.

Bon voyage: A transcriptional journey around DNA breaks.

Caron P, van der Linden J, van Attikum H.

DNA Repair (Amst). 2019 Oct;82:102686. doi: 10.1016/j.dnarep.2019.102686. Epub 2019 Aug 7. Review.

15.

Acquired von Willebrand's syndrome caused by primary hypothyroidism in a 5-year-old girl.

Flot C, Oliver I, Caron P, Savagner F, Tauber M, Claeyssens S, Edouard T.

J Pediatr Endocrinol Metab. 2019 Nov 26;32(11):1295-1298. doi: 10.1515/jpem-2019-0082.

PMID:
31472063
16.

Multinodular goitre is a gateway for molecular testing of DICER1 syndrome.

Oliver-Petit I, Bertozzi AI, Grunenwald S, Gambart M, Pigeon-Kerchiche P, Sadoul JL, Caron PJ, Savagner F.

Clin Endocrinol (Oxf). 2019 Nov;91(5):669-675. doi: 10.1111/cen.14074. Epub 2019 Sep 13.

PMID:
31408196
17.

Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia.

Allain EP, Rouleau M, Le T, Vanura K, Villeneuve L, Caron P, Turcotte V, Lévesque E, Guillemette C.

Front Oncol. 2019 Jul 4;9:606. doi: 10.3389/fonc.2019.00606. eCollection 2019.

18.

Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.

Vitellius G, Delemer B, Caron P, Chabre O, Bouligand J, Pussard E, Trabado S, Lombes M.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5205-5216. doi: 10.1210/jc.2019-00800.

PMID:
31225872
19.

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

Caron P, Pankotai T, Wiegant WW, Tollenaere MAX, Furst A, Bonhomme C, Helfricht A, de Groot A, Pastink A, Vertegaal ACO, Luijsterburg MS, Soutoglou E, van Attikum H.

Genes Dev. 2019 Jun 1;33(11-12):684-704. doi: 10.1101/gad.321943.118. Epub 2019 May 2.

20.

Incidence of thyroid dysfunctions during treatment with nivolumab for non-small cell lung cancer: Retrospective study of 105 patients.

Campredon P, Mouly C, Lusque A, Bigay-Game L, Bousquet E, Mazières J, Caron P.

Presse Med. 2019 Apr;48(4):e199-e207. doi: 10.1016/j.lpm.2018.10.019. Epub 2019 Apr 17.

PMID:
31005502
21.

A mediational model linking perceptions of security, alexithymia and behavior problems of sexually abused children.

Boisjoli C, Hébert M, Gauthier-Duchesne A, Caron PO.

Child Abuse Negl. 2019 Jun;92:66-76. doi: 10.1016/j.chiabu.2019.03.017. Epub 2019 Mar 29.

PMID:
30933832
22.

Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.

Émond JP, Labriet A, Desjardins S, Rouleau M, Villeneuve L, Hovington H, Brisson H, Lacombe L, Simonyan D, Caron P, Périgny M, Têtu B, Fallon JK, Klein K, Smith PC, Zanger UM, Guillemette C, Lévesque E.

Drug Metab Dispos. 2019 May;47(5):444-452. doi: 10.1124/dmd.119.086330. Epub 2019 Feb 28.

PMID:
30819787
23.

Medical therapy in patients with endogenous hypoglycaemia: Is euglycaemia achievable?

Vezzosi D, Guillaume E, Bennet A, Mouly C, Hanaire H, Caron P.

Clin Endocrinol (Oxf). 2019 Jun;90(6):798-804. doi: 10.1111/cen.13961. Epub 2019 Mar 25.

PMID:
30817011
24.

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.

Borchmann S, Joffe E, Moskowitz CH, Zelenetz AD, Noy A, Portlock CS, Gerecitano JF, Batlevi CL, Caron PC, Drullinsky P, Hamilton A, Hamlin PA Jr, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens CN, Palomba ML, Younes A, Straus DJ.

Blood. 2019 May 16;133(20):2121-2129. doi: 10.1182/blood-2018-10-877761. Epub 2019 Feb 15.

PMID:
30770396
25.

Multilevel analysis of matching behavior.

Caron PO.

J Exp Anal Behav. 2019 Mar;111(2):183-191. doi: 10.1002/jeab.510. Epub 2019 Feb 13.

PMID:
30758057
26.

A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer.

Lévesque E, Caron P, Lacombe L, Turcotte V, Simonyan D, Fradet Y, Aprikian A, Saad F, Carmel M, Chevalier S, Guillemette C.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):701-706. doi: 10.1158/1055-9965.EPI-18-1002. Epub 2019 Feb 7.

PMID:
30733309
27.

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.

Hescot S, Curras-Freixes M, Deutschbein T, van Berkel A, Vezzosi D, Amar L, de la Fouchardière C, Valdes N, Riccardi F, Do Cao C, Bertherat J, Goichot B, Beuschlein F, Drui D, Canu L, Niccoli P, Laboureau S, Tabarin A, Leboulleux S, Calsina B, Libé R, Faggiano A, Schlumberger M, Borson-Chazot F, Mannelli M, Gimenez-Roqueplo AP, Caron P, Timmers HJLM, Fassnacht M, Robledo M, Borget I, Baudin E; European Network for the Study of Adrenal Tumors (ENS@T).

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374. doi: 10.1210/jc.2018-01968.

PMID:
30715419
28.

An update on clinical care for pregnant women with acromegaly.

Chanson P, Vialon M, Caron P.

Expert Rev Endocrinol Metab. 2019 Mar;14(2):85-96. doi: 10.1080/17446651.2019.1571909. Epub 2019 Jan 30.

PMID:
30696300
29.

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.

Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G, Else T, Dvorakova S, Qi XP, Elisei R, Maia AL, Glod J, Lourenço DM Jr, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Patocs A, Bugalho MJ, Lacroix A, Caron P, Fainstein-Day P, Borson Chazot F, Klein M, Links TP, Letizia C, Fugazzola L, Chabre O, Canu L, Cohen R, Tabarin A, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Brue T, Mirebeau-Prunier D, Leclerc L, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Barontini M, Vaz Ferreira Vargas C, Valerio L, Ceolin L, Akshintala S, Hoff A, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E.

Lancet Diabetes Endocrinol. 2019 Mar;7(3):213-220. doi: 10.1016/S2213-8587(18)30336-X. Epub 2019 Jan 16. Erratum in: Lancet Diabetes Endocrinol. 2019 Mar;7(3):e3.

PMID:
30660595
30.

Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).

Vinault S, Mariet AS, Le Bras M, Mirallié E, Cardot-Bauters C, Pattou F, Ruszniewski P, Sauvanet A, Chanson P, Baudin E, Elias D, Menegaux F, Gaujoux S, Borson-Chazot F, Lifante JC, Caron P, Carrère N, Tabarin A, Laurent C, Klein M, Brunaud L, Niccoli P, Sebag F, Cadiot G, Kianmanesh R, Luu M, Binquet C, Goudet P.

Ann Surg. 2018 Dec 21. doi: 10.1097/SLA.0000000000003162. [Epub ahead of print]

PMID:
30585820
31.

MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma: PRIMARYS post-hoc analysis.

Bonneville F, Rivière LD, Petersenn S, Bevan J, Houchard A, Sert C, Caron PJ; PRIMARYS Study group.

Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0254.R2. doi: 10.1530/EJE-18-0254. [Epub ahead of print]

PMID:
30540560
32.

An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives.

Caron P, Turcotte V, Lévesque E, Guillemette C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 1;1104:249-255. doi: 10.1016/j.jchromb.2018.12.003. Epub 2018 Dec 4.

PMID:
30537624
33.

French Endocrine Society Guidance on endocrine side-effects of immunotherapy.

Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F.

Endocr Relat Cancer. 2018 Oct 1. pii: ERC-18-0320.R1. doi: 10.1530/ERC-18-0320. [Epub ahead of print]

34.

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.

Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, Renoult PP, Houchard A, Elaraki F, Chanson P.

Endocrine. 2019 Jan;63(1):130. doi: 10.1007/s12020-018-1789-8.

35.

Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.

Tramunt B, Imbert P, Grunenwald S, Boutault F, Caron P.

Clin Endocrinol (Oxf). 2019 Jan;90(1):208-213. doi: 10.1111/cen.13880. Epub 2018 Nov 19.

PMID:
30339291
36.

Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.

Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, Renoult PP, Houchard A, Elaraki F, Chanson P.

Endocrine. 2019 Jan;63(1):120-129. doi: 10.1007/s12020-018-1764-4. Epub 2018 Sep 29. Erratum in: Endocrine. 2018 Oct 31;:.

37.

[Toxicity of immune checkpoints inhibitors].

Delaunay M, Caron P, Sibaud V, Godillot C, Collot S, Milia J, Prévot G, Mazières J.

Rev Mal Respir. 2018 Dec;35(10):1028-1038. doi: 10.1016/j.rmr.2017.08.006. Epub 2018 Sep 10. Review. French.

PMID:
30213624
38.

Expert opinion on thyroid complications in immunotherapy.

Illouz F, Drui D, Caron P, Do Cao C.

Ann Endocrinol (Paris). 2018 Oct;79(5):555-561. doi: 10.1016/j.ando.2018.07.007. Epub 2018 Jul 25. Review.

PMID:
30126627
39.

Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitors.

Drui D, Illouz F, Do Cao C, Caron P.

Ann Endocrinol (Paris). 2018 Oct;79(5):569-573. doi: 10.1016/j.ando.2018.07.003. Epub 2018 Jul 11. Review.

PMID:
30126626
40.

Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.

Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F.

Ann Endocrinol (Paris). 2018 Oct;79(5):591-595. doi: 10.1016/j.ando.2018.07.005. Epub 2018 Jul 11. Review.

PMID:
30056975
41.

Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A Post Hoc Analysis of the PR.7 Trial.

Toren P, Hoffman A, Ding K, Joncas FH, Turcotte V, Caron P, Pouliot F, Fradet Y, Lévesque É, Guillemette C, Klotz L.

Clin Cancer Res. 2018 Nov 1;24(21):5305-5312. doi: 10.1158/1078-0432.CCR-18-1187. Epub 2018 Jul 18.

42.

Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions.

Perreault M, Wunsch E, Białek A, Trottier J, Verreault M, Caron P, Poirier GG, Milkiewicz P, Barbier O.

Can J Gastroenterol Hepatol. 2018 Apr 11;2018:8096314. doi: 10.1155/2018/8096314. eCollection 2018.

43.

Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.

Petrick JL, Hyland PL, Caron P, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Weinstein SJ, Albanes D, Freedman ND, Gapstur SM, Bradwin G, Guillemette C, Campbell PT, Cook MB.

J Natl Cancer Inst. 2019 Jan 1;111(1):34-41. doi: 10.1093/jnci/djy082.

44.

Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.

Allain EP, Venzl K, Caron P, Turcotte V, Simonyan D, Gruber M, Le T, Lévesque E, Guillemette C, Vanura K.

Ann Hematol. 2018 Sep;97(9):1649-1661. doi: 10.1007/s00277-018-3356-z. Epub 2018 May 21.

45.

Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment.

Campredon P, Imbert P, Mouly C, Grunenwald S, Mazières J, Caron P.

Eur Thyroid J. 2018 Mar;7(2):84-87. doi: 10.1159/000485742. Epub 2018 Jan 4.

46.

Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study.

Petrick JL, Falk RT, Hyland PL, Caron P, Pfeiffer RM, Wood SN, Dawsey SM, Abnet CC, Taylor PR, Guillemette C, Murray LJ, Anderson LA, Cook MB.

PLoS One. 2018 Jan 17;13(1):e0190325. doi: 10.1371/journal.pone.0190325. eCollection 2018.

47.

Food systems for sustainable development: proposals for a profound four-part transformation.

Caron P, Ferrero Y de Loma-Osorio G, Nabarro D, Hainzelin E, Guillou M, Andersen I, Arnold T, Astralaga M, Beukeboom M, Bickersteth S, Bwalya M, Caballero P, Campbell BM, Divine N, Fan S, Frick M, Friis A, Gallagher M, Halkin JP, Hanson C, Lasbennes F, Ribera T, Rockstrom J, Schuepbach M, Steer A, Tutwiler A, Verburg G.

Agron Sustain Dev. 2018;38(4):41. doi: 10.1007/s13593-018-0519-1. Epub 2018 Aug 9.

48.

Severe thyrotoxicosis in an infant revealing familial nonautoimmune hyperthyroidism with a novel (C672W) stimulating thyrotropin receptor germline mutation.

Oliver-Petit I, Savagner F, Grunenwald S, Vialon M, Edouard T, Caron P.

Clin Case Rep. 2017 Oct 25;5(12):1980-1987. doi: 10.1002/ccr3.1178. eCollection 2017 Dec.

49.

L’hypophyse et ses traitements : comment peuvent-ils influer sur le comportement ?: The pituitary and its treatments: how can they influence behaviour?

Mouly C, Borson-Chazot F, Caron P.

Ann Endocrinol (Paris). 2017 Oct;78 Suppl 1:S41-S49. doi: 10.1016/S0003-4266(17)30924-1. Review. French.

PMID:
29157488
50.

Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.

Audet-Delage Y, Grégoire J, Caron P, Turcotte V, Plante M, Ayotte P, Simonyan D, Villeneuve L, Guillemette C.

J Steroid Biochem Mol Biol. 2018 Apr;178:45-54. doi: 10.1016/j.jsbmb.2017.10.021. Epub 2017 Oct 29.

PMID:
29092787

Supplemental Content

Support Center